Portfolio

Investment footprint

  • Libentech

    Biotech developing DMD
    therapeutics using their
    proprietary recombinant virus
    vector platform technology.

    Visite to Website
  • IPP

    CRO supporting global healthcare
    and pharmaceutical companies
    with technology and services to
    accelerate drug development

    Visite to Website
  • Celros Biotech

    Biotechnology company
    developing anti-inflammatory
    therapeutics regulating
    activity of NADPH oxidases.

    Visite to Website
  • MD Healthcare

    A microbiome company
    developing breakthrough
    precision medicine solutions in
    both diagnostics and therapeutics.

    Visite to Website
  • Generoath

    Biotechnology company
    developing AAV based gene
    therapeutics for ALS and PD.

    Visite to Website
  • Oncocross

    AI based pharmaceutical
    company specializing in drug
    discovery and development
    of oncology based therapeutics.

    Visite to Website
  • RadiSen

    A leading developer and
    manufacturer in AI-based
    digital radiography products
    for lung diseases.

    Visite to Website
  • Curacle

    Biotechnology company
    developing innovative drugs
    for incurable diseases caused
    by the aging process and
    damage to blood vessels.

    Visite to Website
  • Aptamer Science

    R&D based bio-venture focused
    on aptamer technology for the
    development of innovative
    therapeutic and diagnostic
    platforms.

    Visite to Website
  • AprilBio

    Biotechnology company
    developing biologics and antibody
    therapeutics using proprietary
    platform technologies.

    Visite to Website
  • Bioceltran

    Bio-venture developing
    high permeable PTD
    technology for
    cosmeceuticals.

    Visite to Website
  • Cooning Soon

  • Cooning Soon

  • Cooning Soon

  • Cooning Soon